Sands, Dorota.
Dorota Sands
VIAF ID: 311811540 (Personal)
Permalink: http://viaf.org/viaf/311811540
Preferred Forms
- 100 0 _ ‡a Dorota Sands
- 100 1 _ ‡a Sands, Dorota
-
-
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial | |
Analiza stężeń wybranych parametrów metabolizmu kostnego u dzieci chorych na mukowscydozę | |
Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency | |
Analysis of hospital management of chronic respiratory diseases in light of the "Maps of Health Needs" project in Poland | |
Application of positive expiratory pressure *PEP* in cystic fibrosis patient inhalations | |
[Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis] | |
Badanie stężenia chkorków w pocie u niemowląt z dodatnim wynikiem testu przesiewowego u ich rodzeństwa | |
Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control | |
Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis | |
Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections | |
Clinical Phenotype and Genotype of Children with Borderline Sweat Test and Abnormal Nasal Epithelial Chloride Transport | |
Clinical status and somatic development of patients with or without meconium ileus diagnosed through neonatal screening for cystic fibrosis. | |
Comparison of health-related quality of life among children with cystic fibrosis and their parents in two Eastern European countries. | |
Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS. | |
Cystic fibrosis newborn screening enables diagnosis of elder siblings of recalled infants--additional benefit | |
Diagnostyka prenatalna mukowiscydozy w rodzinach ryzyka w Polsce : wyniki badań molekularnych | |
End of Life: Have we got it right? | |
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre | |
The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. | |
Farmakoterapia mukowiscydozy | |
Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis | |
Gastroesophageal Reflux Disease in Children with Cystic Fibrosis | |
Genetyczne markery ryzyka wystąpienia obniżonej gęstości mineralnej tkanki kostnej u dzieci w mukowiscydozą | |
'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020 | |
Impact of lipophilic antioxidants and level of antibodies against oxidized low-density lipoprotein in Polish children with phenylketonuria. | |
Influence of perfusate temperature on nasal potential difference. | |
Insights into the cystic fibrosis care in Eastern Europe: Results of survey | |
An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. | |
Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients. | |
[Long-term evaluation of effectiveness for selected chest physiotherapy methods used in the treatment of cystic fibrosis] | |
Mild CFTR mutations and genetic predisposition to lactase persistence in cystic fibrosis | |
Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results | |
Mukowiscydoza : choroba wieloukładowa | |
Mukowiscydoza dla pediatrów i lekarzy rodzinnych | |
Mukowiscydoza : różnorodność fenotypowa i wyzwania diagnostyczne | |
Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy | |
Niejednoznaczna diagnoza mukowiscydozy u dzieci z pozytywnym wynikiem badania przesiewowego = Inconclusive diagnosis of cystic fibrosis in children with positive newborn screening | |
A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients. | |
[Nutritional status and pulmonary function in children and adolescents with cystic fibrosis] | |
Ocena radiologiczna płuc u dzieci z mukowiscydozą rozpoznaną w wyniku badania przesiewowego noworodków | |
Ocena stanu odżywienia oraz czynności płuc dzieci i młodzieży z mukowiscydozą | |
Physical development in children and adolescents with bronchial asthma. | |
Polska adaptacja Kwestionariusza Jakości Życia przeznaczonego dla dzieci i dorosłych chorych na mukowiscydozę oraz ich rodziców (CFQ-R) | |
Possible metabolic switch between environmental and pathogenic Pseudomonas aeruginosa strains: 1H NMR based metabolomics study | |
[Prenatal diagnosis of cystic fibrosis in risk families in Poland--results of molecular analysis] | |
Prostaglandin-endoperoxide synthase genes COX1 and COX2 : novel modifiers of disease severity in cystic fibrosis patients | |
Przydatność oznaczania lipazy po stymulacji sekretyną w diagnostyce łagodnej niewydolności zewnątrzwydzielniczej trzustki u chorych na mukowiscydozę | |
Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. | |
Renal assessment in teenage patients with cystic fibrosis - preliminary report. | |
Rozpoznawanie i leczenie mukowiscydozy : podsumowanie wytycznych European Cystic Fibrosis Society 2018 | |
Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis. | |
[Silent lung zone - application of multi-breath nitrogen washout test (MBNW) in the diagnosis of small airways diseases in children - preliminary report based on literature and own experience]. | |
Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: wytyczne i najlepsze praktyki | |
[A study evaluating the correlation between the phenotype and genotype among 65 cystic fibrosis patients] | |
Sytuacja chorych na choroby rzadkie w czasie pandemii koronawirusa SARS-CoV-2 | |
Thiocyanate concentration in saliva of cystic fibrosis patients | |
Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF) | |
Uncommon clinical presentation of cystic fibrosis in a patient homozygous for a rare CFTR mutation: a case report | |
VI spotkanie Rady Ekspertów ds. Chorób Rzadkich Medycznej Racji Stanu | |
Wczesne rozpoznawanie nietolerancji glukozy i/lub cukrzycy u dzieci chorych na mukowiscydozę | |
Zakażenie gronkowcem złocistym u chorych na mukowiscydozę : profilaktyka, leczenie i eradykacja | |
Zapalenie stawów w przebiegu mukowiscydozy u dzieci | |
Zasady rozpoznawania i leczenia mukowiscydozy : zalecenia Polskiego Towarzystwa Mukowiscydozy 2009 Poznań - Warszawa - Rzeszów | |
Zastosowanie Cystilacu w leczeniu żywieniowym chorych na CF | |
Zborník prednášok z V4-CF konferencie : book of presentations from V4-CF conference |